WOONSOCKET – Onset Therapeutics, a pharmaceutical firm focusing on the development and commercialization of topical products for skin and wound-related disorders, announced Wednesday that it has completed building its commercial organization and plans to launch the first in a series of prescription products in the wound care market this May.
The product will be officially launched at the upcoming Symposium on Advanced Wound Care meeting in San Antonio, April 30 to May 2.
Rhode Island's Market Has Changed. Developers, Builders, Investors and Sellers Must Change With It.
By Emilio DiSpirito IV License Partner | Engel & Völkers Oceanside Leader | The DiSpirito…
Learn More
Development and commercialization of therapies with clinical enhancements over existing products in the market is the core of Onset’s strategy, the company said. The company looks to market numerous topical products within the wound care and dermatology markets in 2006. In addition, the company has products that it intends to launch over the next three years.
“We strive to provide novel, optimized and cost-effective pharmaceutical products to the health care market,” said Michael Heffernan, president of Onset Therapeutics, in a statement.
Onset expects to launch several wound care products this year, in addition to numerous dermatology products incorporating the company’s “foam vehicle technology.”
The company’s Web site is www.onsettx.com.
